Stem cell growth factor shows promise as Alzheimer's treatment

07/2/2009 | New Kerala (India)

A U.S. study on Alzheimer's disease mice models found that injections of the granulocyte-colony stimulating factor -- a human growth factor used to trigger blood stem cell production in the bone marrow -- reduced the levels of beta amyloid protein that is considered a hallmark of the disease, as well as increased neuron production and promoted nerve-cell connections. The results indicate that the growth factor shows promise as a treatment "that may actually reverse disease, not just alleviate symptoms like currently available drugs," the lead author said.

View Full Article in:

New Kerala (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX